These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6067204)

  • 21. [Incidence of and mortality from cancer of the uterine cervix in England: results of a 30-year screening].
    Vallée JP
    Presse Med; 1999 Oct; 28(31):1699-700. PubMed ID: 10554611
    [No Abstract]   [Full Text] [Related]  

  • 22. [Systematic screening for cancer of the uterine cervix (epidemiologic aspects)].
    Campion J; Flamant R
    Bull Inst Natl Sante Rech Med; 1966; 21(5):977-94. PubMed ID: 5976404
    [No Abstract]   [Full Text] [Related]  

  • 23. [Present status of mass screening of cancer of the uterine cervix].
    Kutsuzawa T; Moriya S; Okubo H; Sakuragi N; Ichinohe K
    Hokkaido Igaku Zasshi; 1986 Jul; 61(4):499-504. PubMed ID: 3758914
    [No Abstract]   [Full Text] [Related]  

  • 24. Smears from the cervix. Cancer cell detection.
    Wells AH; Kundel DW; Helwig KL; Michaelis DL; Goldschmidt VG
    Minn Med; 1968 Jan; 51(1):25-9. PubMed ID: 5636225
    [No Abstract]   [Full Text] [Related]  

  • 25. Cervical cancer screening programs. II. Screening for carcinoma of the cervix.
    Can Med Assoc J; 1976 Jun; 114(11):1013-26. PubMed ID: 776379
    [No Abstract]   [Full Text] [Related]  

  • 26. Evaluation of the effectiveness of cytologic screening for cervical cancer. I. Incidence and mortality trends in relation to screening.
    Dickinson L; Mussey ME; Soule EH; Kurland LT
    Mayo Clin Proc; 1972 Aug; 47(8):534-44. PubMed ID: 5049157
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effectiveness of the model used for screening and early diagnosis of cervical cancer in Karelia].
    Kovchur PI; Bakhidze EV
    Vopr Onkol; 2014; 60(3):298-305. PubMed ID: 25033680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer of the cervix uteri in Arkansas.
    Felts SK; Utterback LR; Ramsay RC
    J Ark Med Soc; 1973 Nov; 70(6):206-7. PubMed ID: 4271177
    [No Abstract]   [Full Text] [Related]  

  • 29. [Mass screening for cancer of the uterine cervix].
    Berget A
    Ugeskr Laeger; 1975 Jul; 137(27):1558-9. PubMed ID: 1145871
    [No Abstract]   [Full Text] [Related]  

  • 30. Mass screening for cervical carcinoma in Finland. Organization and effect on morbidity and mortality.
    Timonen S; Nieminen U; Kauraniemi T
    Ann Chir Gynaecol Fenn; 1974; 63(2):104-12. PubMed ID: 4853102
    [No Abstract]   [Full Text] [Related]  

  • 31. Twenty years' screening for cancer of the uterine cervix in Great Britain, 1964-84: further evidence for its ineffectiveness.
    Murphy MF; Campbell MJ; Goldblatt PO
    J Epidemiol Community Health; 1988 Mar; 42(1):49-53. PubMed ID: 3418286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening for cervical neoplasia. A survey of the assumptions from studies on the screening in Maribo Amt.
    Berget A
    Dan Med Bull; 1979 Nov; 26(7):313-32. PubMed ID: 118850
    [No Abstract]   [Full Text] [Related]  

  • 33. A preliminary investigation into the incidence of cancer of the cervix.
    Te Groen LH; Rose EF
    S Afr Med J; 1974 Nov; 48(57):2341-5. PubMed ID: 4432184
    [No Abstract]   [Full Text] [Related]  

  • 34. [Leading trends in the evaluation of programs to control death and incapacitation by cancer of the uterine cervix].
    de la Puente JL
    Salud Publica Mex; 1979; 21(5):573-81. PubMed ID: 550328
    [No Abstract]   [Full Text] [Related]  

  • 35. [Importance of cancer of the cervix in Cataluña: considerations on an eventual screening program].
    Spagnolo de la Torre E; Segura Benedicto A; Vila Macau R; Andrés Martínez J; Sans Menéndez S
    Med Clin (Barc); 1984 Jan; 82(2):83-6. PubMed ID: 6708615
    [No Abstract]   [Full Text] [Related]  

  • 36. [A retrospective study of carcinoma of the uterine cervix and the value of cytological cervix studies in healthy women].
    Barentsz JO; Muizebelt F; van der Schee AC; Toonen-van Beek AA
    Ned Tijdschr Geneeskd; 1979 Nov; 123(45):1932-6. PubMed ID: 514382
    [No Abstract]   [Full Text] [Related]  

  • 37. Health policy: gaps in access, delivery, and utilization of the Pap smear in the United States.
    Baquet C; Ringen K
    Milbank Q; 1987; 65 Suppl 2():322-47. PubMed ID: 3451061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of cervical cancer screening.
    Pettersson F
    Med Oncol Tumor Pharmacother; 1991; 8(3):175-81. PubMed ID: 1803178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emerging technologies and cervical cancer.
    Follen M; Richards-Kortum R
    J Natl Cancer Inst; 2000 Mar; 92(5):363-5. PubMed ID: 10699061
    [No Abstract]   [Full Text] [Related]  

  • 40. Early case finding, treatment and mortality from cervix and breast cancer.
    Breslow L
    Prev Med; 1972 Mar; 1(1):141-52. PubMed ID: 5068997
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.